Yes but the glaring failure of BRN's inept marketing is that their B2B efforts have failed in convincing anyone to make a commercial technology decision in favour of AKIDA. This has to be a multi faceted approach, if AKIDA is actually as good as BRN reckon it is then they have to start making that knowledge mainstream. The more people who are aware of AKIDA and its capacity to improve people's lives then the more likely a commercial partner will jump on board.
EDGE BOX, page-83
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $313.9M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 16.0¢ | $22.07K | 133.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 598078 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 1288083 | 26 |
View Market Depth
| Last trade - 10.17am 12/09/2024 (20 minute delay) ? |
| BRN (ASX) Chart |